A detailed history of Nemes Rush Group LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Nemes Rush Group LLC holds 100 shares of AZN stock, worth $6,663. This represents 0.0% of its overall portfolio holdings.

Number of Shares
100
Previous 100 -0.0%
Holding current value
$6,663
Previous $7.8 Million 13.13%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

SELL
$66.81 - $80.83 $30,665 - $37,100
-459 Reduced 82.11%
100 $7.8 Million
Q1 2024

May 15, 2024

SELL
$61.03 - $69.57 $122 - $139
-2 Reduced 0.36%
559 $37.9 Million
Q4 2023

Feb 09, 2024

BUY
$61.89 - $69.28 $8,231 - $9,214
133 Added 31.07%
561 $37.8 Million
Q3 2023

Nov 09, 2023

BUY
$64.85 - $71.7 $21,919 - $24,234
338 Added 375.56%
428 $29 Million
Q2 2023

Aug 02, 2023

BUY
$69.91 - $75.81 $6,291 - $6,822
90 New
90 $6.44 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $206B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Nemes Rush Group LLC Portfolio

Follow Nemes Rush Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nemes Rush Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nemes Rush Group LLC with notifications on news.